glaucoma and semaglutide Semaglutides linked to serious eye condition The Ophthalmologist | Semaglutide Blindness

Tirzepatide was approved in 2022 as Mounjaro for diabetes, and in 2024 as Zepbound for obesity, with exclusivity running until May 2027

GLP-1 medications like semaglutide reduce appetite and slow stomach emptying, which can create nutritional gaps

Rybelsus (oral semaglutide) vs Ozempic (injectable semaglutide) for Canadians

Whether youre right at the beginning of your weight loss journey using GLP-1 medications or youre already seeing positive results, it can be a daunting process full of ups and downs. GLP-1 medications like Wegovy and Mounjaro are helpful tools for supporting weight management because they